Unique features of human cathelicidin LL-37
PBN-AR
Instytucja
Wydział Matematyczno-Przyrodniczy (Uniwersytet Humanistyczno-Przyrodniczy im. Jana Długosza w Częstochowie)
Informacje podstawowe
Główny język publikacji
EN
Czasopismo
BioFactors
ISSN
0951-6433
EISSN
1872-8081
Wydawca
WILEY-BLACKWELL
DOI
URL
Rok publikacji
2015
Numer zeszytu
5
Strony od-do
289-300
Numer tomu
41
Identyfikator DOI
Liczba arkuszy
Słowa kluczowe
EN
cathelicidin
LL-37
immune system
inflammation
anti-microbial properties
Streszczenia
Język
EN
Treść
Cathelicidins are antimicrobial peptides produced by humans and animals in response to various pathogenic microbes. This review intends to provide a brief overview of the expression, structure, properties and function of human cathelicidin LL-37 which may be a therapeutic agent against a variety of bacterial and viral diseases, cancers, and hard-to-heal wounds. Cathelicidins act as a primary defense against bacteria and other pathogens in the case of inflammation. They are able to kill bacteria and fungi, inhibit and destroy bacterial biofilms, and possess antiviral and antiparasitics properties. They can also play a role in angiogenesis, wound healing, and the regulation of apoptosis. The host defense peptide LL-37 has emerged as a novel modulator of tumor growth and metastasis in carcinogenesis of various types of cancers. LL-37 is an antimicrobial peptide able of inducing various effects. It acts as an anti- and pro- inflammatory factor. Cathelicidins are able to directly and selectively destroy membranes of various microbes and cancer cells, but they do not attack normal cells. The role of cathelicidins in cancer is double-sided. They play an important role in killing cancer cells and may provide a new possibility for the development of cancer therapeutics. However, they also can participate in carcinogenesis. Due to its activity spectrum LL-37 could be applied in pharmacotherapy. Cathelicidin peptides could serve as a template for the development of modern anti-microbial and anti-viral drugs. LL-37 is an excellent candidate to develop into therapeutics for infected wounds
Cechy publikacji
Artykuł przeglądowy
Zrecenzowana naukowo
Inne
System-identifier
PX-56b463f58106eb71826e46ae
CrossrefMetadata from Crossref logo
Cytowania
Liczba prac cytujących tę pracę
Brak danych
Referencje
Liczba prac cytowanych przez tę pracę
Brak danych